PropertyValue
?:abstract
  • Developers of severe acute respiratory syndrome coronavirus 2 vaccines should consider some of the lessons from a \'new\' vaccine introduced in 1921, namely bacille Calmette-Guérin.
  • Developers of severe acute respiratory syndrome coronavirus 2 vaccines should consider some of the lessons from a “new” vaccine introduced in 1921, namely bacille Calmette-Guérin.
?:creator
?:doi
  • 10.1093/infdis/jiaa637
?:doi
?:journal
  • J_Infect_Dis
  • The_Journal_of_infectious_diseases
?:license
  • no-cc
  • unk
?:pdf_json_files
  • document_parses/pdf_json/c696c0cce14a98c39c5e0ba724b6b3cce0267f4b.json
?:pmc_json_files
  • document_parses/pmc_json/PMC7798939.xml.json
?:pmcid
?:pmid
?:pmid
  • 33252679.0
  • 33535239
?:publication_isRelatedTo_Disease
?:sha_id
?:source
  • Medline
  • Medline; PMC
?:title
  • Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates
  • Lessons From Bacille Calmette-Guérin for SARS-CoV-2 Vaccine Candidates.
?:type
?:year
  • 2020-11-30
  • 2021-02-03

Metadata

Anon_0  
expand all